<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05799508</url>
  </required_header>
  <id_info>
    <org_study_id>ID 3777</org_study_id>
    <nct_id>NCT05799508</nct_id>
  </id_info>
  <brief_title>Consequences of COVID-19 Infection for Child Health and Wellbeing: Protocol for a Prospective, Observational, Longitudinal Study in Children</brief_title>
  <official_title>Consequences of COVID-19 Infection for Child Health and Wellbeing: Protocol for a Prospective, Observational, Longitudinal Study in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective follow-up of children with SARS-CoV-2&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Actual">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of children developing long covid</measure>
    <time_frame>up to 36 months</time_frame>
    <description>prevalence of post covid condition at 3-6-12-18-24-36 months after SARS-CoV-3 infection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>duration and characteristics of children with long covid, also according to variants</measure>
    <time_frame>up to 36 months</time_frame>
    <description>prevalence of post covid condition according to the original SARS-CoV-2 variant at 3-6-12-18-24-36 months after SARS-CoV-3 infection</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Long COVID</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of patients diagnosed with COVID-19 and admitted to the&#xD;
        hospitals and/or assessed in primary care among our Institution. Patients will be&#xD;
        identified from existing local cohorts.&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          -  Children aged 0-18 years&#xD;
&#xD;
          -  The child sought/needed primary or secondary medical care for COVID-19&#xD;
&#xD;
          -  Laboratory (RT-PCR,) [18]&#xD;
&#xD;
          -  28 days - 3 months from the onset of COVID-19 symptoms&#xD;
&#xD;
          -  Parent's/carer's/guardian's consent to participate The survey for paediatric follow-up&#xD;
             is based on the previously developed adult questionnaire. The survey has been adapted&#xD;
             to specific age groups to identify specific symptoms in children.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children aged 0-18 years&#xD;
&#xD;
          -  The child sought/needed primary or secondary medical care for COVID-19&#xD;
&#xD;
          -  Laboratory (RT-PCR,) [18]&#xD;
&#xD;
          -  28 days - 3 months from the onset of COVID-19 symptoms&#xD;
&#xD;
          -  Parent's/carer's/guardian's consent to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  adults&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Weeks</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gemelli</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>danilo buonsenso, md</last_name>
      <phone>3319819715</phone>
      <email>danilobuonsenso@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2023</verification_date>
  <study_first_submitted>March 29, 2023</study_first_submitted>
  <study_first_submitted_qc>April 4, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2023</study_first_posted>
  <last_update_submitted>April 4, 2023</last_update_submitted>
  <last_update_submitted_qc>April 4, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>to contact the PI, sharing planned with GBD</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

